{"title":"超声引导下牛气管软骨素多硫酸盐联合点阵二氧化碳激光治疗烧伤修复后瘢痕的临床疗效。","authors":"Jianjun Zhou, Xiaojun Huang, Meijie Chen, Xiaofang Chen, Jiong Chen","doi":"10.5114/ada.2024.141110","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>One common and very upsetting side effect of burn injuries is scarring, which presents serious difficulties for patients and medical professionals alike.</p><p><strong>Aim: </strong>To assess a new therapeutic approach for treating scars following burn repair procedures in terms of its clinical efficacy.</p><p><strong>Material and methods: </strong>This method administers Hirudoid under ultrasound guidance in addition to fractional CO<sub>2</sub> laser treatment. An extensive analysis of the effects of this combination treatment on functional results, patient satisfaction, and scar appearance is being conducted as part of this research. Fractional CO<sub>2</sub> laser treatment is utilized for its capacity to stimulate collagen remodelling and decrease scar hypertrophy, while Hirudoid, a topical medicine containing heparinoid, is used to minimize inflammation and enhance tissue healing. Enrolling patients who have had burn repair surgery is the goal of a quasi-experimental study. Conventional scar care methods are performed on the control group, whereas the experimental group is treated with fractional CO<sub>2</sub> laser therapy after applying Hirudoid under ultrasound guidance. Throughout the research period, clinical evaluations are carried out on a regular basis. These evaluations cover scar features, pain thresholds, and patient-reported results.</p><p><strong>Results: </strong>The first findings show that the experimental group significantly outperformed the control group in terms of overall look, pigmentation, and scar texture. Functional examinations point to possible improvements in terms of scar flexibility and the range of motion, while patient-reported outcomes show improved satisfaction with the combination therapy. In order to guarantee the combination therapy's viability and tolerance in a clinical context, its side effects and safety profiles are also extensively assessed. In order to improve scar management following burn healing, the study intends to provide important insights into the creation of more patient-friendly and successful therapies.</p><p><strong>Conclusions: </strong>A potential approach to enhancing the clinical results of burn scar treatment is the study of fractional CO<sub>2</sub> laser therapy in conjunction with ultrasound-guided Hirudoid. Enhancing scar management tactics via the combination of sophisticated technology and therapy modalities may eventually improve the quality of life for burn injury victims.</p>","PeriodicalId":54595,"journal":{"name":"Postepy Dermatologii I Alergologii","volume":null,"pages":null},"PeriodicalIF":1.4000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11253313/pdf/","citationCount":"0","resultStr":"{\"title\":\"Clinical efficacy of ultrasound-guided chondroitin polysulfate from bovine trachea combined with fractional CO<sub>2</sub> laser in the treatment of scar after burn repair.\",\"authors\":\"Jianjun Zhou, Xiaojun Huang, Meijie Chen, Xiaofang Chen, Jiong Chen\",\"doi\":\"10.5114/ada.2024.141110\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>One common and very upsetting side effect of burn injuries is scarring, which presents serious difficulties for patients and medical professionals alike.</p><p><strong>Aim: </strong>To assess a new therapeutic approach for treating scars following burn repair procedures in terms of its clinical efficacy.</p><p><strong>Material and methods: </strong>This method administers Hirudoid under ultrasound guidance in addition to fractional CO<sub>2</sub> laser treatment. An extensive analysis of the effects of this combination treatment on functional results, patient satisfaction, and scar appearance is being conducted as part of this research. Fractional CO<sub>2</sub> laser treatment is utilized for its capacity to stimulate collagen remodelling and decrease scar hypertrophy, while Hirudoid, a topical medicine containing heparinoid, is used to minimize inflammation and enhance tissue healing. Enrolling patients who have had burn repair surgery is the goal of a quasi-experimental study. Conventional scar care methods are performed on the control group, whereas the experimental group is treated with fractional CO<sub>2</sub> laser therapy after applying Hirudoid under ultrasound guidance. Throughout the research period, clinical evaluations are carried out on a regular basis. These evaluations cover scar features, pain thresholds, and patient-reported results.</p><p><strong>Results: </strong>The first findings show that the experimental group significantly outperformed the control group in terms of overall look, pigmentation, and scar texture. Functional examinations point to possible improvements in terms of scar flexibility and the range of motion, while patient-reported outcomes show improved satisfaction with the combination therapy. In order to guarantee the combination therapy's viability and tolerance in a clinical context, its side effects and safety profiles are also extensively assessed. In order to improve scar management following burn healing, the study intends to provide important insights into the creation of more patient-friendly and successful therapies.</p><p><strong>Conclusions: </strong>A potential approach to enhancing the clinical results of burn scar treatment is the study of fractional CO<sub>2</sub> laser therapy in conjunction with ultrasound-guided Hirudoid. Enhancing scar management tactics via the combination of sophisticated technology and therapy modalities may eventually improve the quality of life for burn injury victims.</p>\",\"PeriodicalId\":54595,\"journal\":{\"name\":\"Postepy Dermatologii I Alergologii\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2024-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11253313/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Postepy Dermatologii I Alergologii\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.5114/ada.2024.141110\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/6/30 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"ALLERGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Postepy Dermatologii I Alergologii","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5114/ada.2024.141110","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/30 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0
摘要
简介:疤痕是烧伤常见的副作用之一,也是非常令人不安的副作用,给患者和医务人员都带来了严重困难:目的:评估一种治疗烧伤修复术后疤痕的新方法的临床疗效:材料和方法:除了点阵二氧化碳激光治疗外,这种方法还在超声波引导下使用Hirudoid。作为这项研究的一部分,我们正在对这种联合疗法在功能效果、患者满意度和疤痕外观方面的效果进行广泛分析。二氧化碳点阵激光疗法可刺激胶原蛋白重塑,减少疤痕肥大,而 Hirudoid 是一种含有肝磷脂的外用药物,可减少炎症,促进组织愈合。这项准实验研究的目标是招募接受过烧伤修复手术的患者。对照组采用传统的疤痕护理方法,而实验组则在超声波引导下使用 Hirudoid 后,再用点阵 CO2 激光疗法进行治疗。在整个研究期间,会定期进行临床评估。这些评估包括疤痕特征、疼痛阈值和患者报告结果:初步结果显示,实验组在整体外观、色素沉着和疤痕质地方面明显优于对照组。功能检查表明,疤痕的柔韧性和活动范围可能有所改善,而患者报告的结果显示,对综合疗法的满意度有所提高。为了保证联合疗法在临床上的可行性和耐受性,还对其副作用和安全性进行了广泛评估。为了改善烧伤愈合后的疤痕管理,该研究旨在为创造更适合患者、更成功的疗法提供重要见解:结论:提高烧伤疤痕治疗临床效果的一种潜在方法是将点阵二氧化碳激光疗法与超声引导下的Hirudoid疗法结合起来进行研究。通过将尖端技术与治疗方法相结合来提高疤痕治疗效果,最终可能会改善烧伤患者的生活质量。
Clinical efficacy of ultrasound-guided chondroitin polysulfate from bovine trachea combined with fractional CO2 laser in the treatment of scar after burn repair.
Introduction: One common and very upsetting side effect of burn injuries is scarring, which presents serious difficulties for patients and medical professionals alike.
Aim: To assess a new therapeutic approach for treating scars following burn repair procedures in terms of its clinical efficacy.
Material and methods: This method administers Hirudoid under ultrasound guidance in addition to fractional CO2 laser treatment. An extensive analysis of the effects of this combination treatment on functional results, patient satisfaction, and scar appearance is being conducted as part of this research. Fractional CO2 laser treatment is utilized for its capacity to stimulate collagen remodelling and decrease scar hypertrophy, while Hirudoid, a topical medicine containing heparinoid, is used to minimize inflammation and enhance tissue healing. Enrolling patients who have had burn repair surgery is the goal of a quasi-experimental study. Conventional scar care methods are performed on the control group, whereas the experimental group is treated with fractional CO2 laser therapy after applying Hirudoid under ultrasound guidance. Throughout the research period, clinical evaluations are carried out on a regular basis. These evaluations cover scar features, pain thresholds, and patient-reported results.
Results: The first findings show that the experimental group significantly outperformed the control group in terms of overall look, pigmentation, and scar texture. Functional examinations point to possible improvements in terms of scar flexibility and the range of motion, while patient-reported outcomes show improved satisfaction with the combination therapy. In order to guarantee the combination therapy's viability and tolerance in a clinical context, its side effects and safety profiles are also extensively assessed. In order to improve scar management following burn healing, the study intends to provide important insights into the creation of more patient-friendly and successful therapies.
Conclusions: A potential approach to enhancing the clinical results of burn scar treatment is the study of fractional CO2 laser therapy in conjunction with ultrasound-guided Hirudoid. Enhancing scar management tactics via the combination of sophisticated technology and therapy modalities may eventually improve the quality of life for burn injury victims.